Interactions between blood cells and retinal endothelium in endotoxic sepsis.
Platelets and leukocytes are thought to play a leading role in the pathogenesis of many inflammatory conditions. To recruit flowing blood cells to the inflammatory region, it would be necessary for them to interact with vascular endothelial cells. Recently, many reports have indicated the resistance of spontaneous hypertensive rats (SHR) to endotoxic sepsis. Their resistance might be derived from suppressed interaction between these blood cells and endothelial cells. Therefore, SHR and age-matched Wistar-Kyoto rats (WKY) were induced with endotoxic sepsis by intravenous injection of lipopolysaccharide (LPS). At 4, 12, 24, and 48 hours after induction, leukocyte-endothelial interactions in the retina were evaluated in vivo with acridine orange digital fluorography. Fluorescently labeled platelets were also injected to investigate platelet-endothelial interactions in the retina in endotoxic sepsis. Leukocyte rolling in SHR after LPS injection was significantly suppressed; the maximum number of rolling leukocytes was reduced by 80.1% at 12 hours after LPS injection in SHR compared with WKY. Subsequent leukocyte infiltration into the vitreous cavity was significantly inhibited in SHR. Furthermore, platelet-endothelial interactions in the retina were also suppressed in SHR treated with LPS. The maximum numbers of rolling and adherent platelets were reduced by 59.5% and 62.6%, respectively, in SHR compared with WKY. In both strains, leukocyte- and platelet-endothelial interactions were substantially inhibited by the blocking of P-selectin. These suppressed interactions could contribute to the reduction of leukocyte- and platelet-mediated tissue injury in endotoxic sepsis in SHR, resulting in their resistance to endotoxemia.
Tsujikawa
A
A
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Japan.
Kiryu
J
J
Yamashiro
K
K
Nonaka
A
A
Nishijima
K
K
Honda
Y
Y
Ogura
Y
Y
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001773:Blood Cells / Q000166:cytology* / Q000187:drug effects; D001792:Blood Platelets / Q000166:cytology / Q000187:drug effects; D002450:Cell Communication; D004730:Endothelium, Vascular / Q000166:cytology* / Q000503:physiopathology; D019446:Endotoxemia; D006973:Hypertension / Q000503:physiopathology; D007958:Leukocyte Count / Q000187:drug effects; D007962:Leukocytes / Q000166:cytology / Q000187:drug effects; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D019007:P-Selectin / Q000276:immunology; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012171:Retinal Vessels / Q000166:cytology* / Q000187:drug effects / Q000503:physiopathology; D018805:Sepsis / Q000503:physiopathology*; D013045:Species Specificity
D000911:Antibodies, Monoclonal; D008070:Lipopolysaccharides; D019007:P-Selectin